@ARTICLE{10.3389/fphy.2017.00032, AUTHOR={Ramezanpour, Abolfazl and Mashaghi, Alireza}, TITLE={Toward First Principle Medical Diagnostics: On the Importance of Disease-Disease and Sign-Sign Interactions}, JOURNAL={Frontiers in Physics}, VOLUME={5}, YEAR={2017}, URL={https://www.frontiersin.org/articles/10.3389/fphy.2017.00032}, DOI={10.3389/fphy.2017.00032}, ISSN={2296-424X}, ABSTRACT={A fundamental problem in medicine and biology is to assign states, e.g., healthy or diseased, to cells, organs or individuals. State assignment or making a diagnosis is often a nontrivial and challenging process and, with the advent of omics technologies, the diagnostic challenge is becoming more and more serious. The challenge lies not only in the increasing number of measured properties and dynamics of the system (e.g., cell or human body) but also in the co-evolution of multiple states and overlapping properties, and degeneracy of states. We develop, from first principles, a generic rational framework for state assignment in cell biology and medicine, and demonstrate its applicability with a few simple theoretical case studies from medical diagnostics. We show how disease–related statistical information can be used to build a comprehensive model that includes the relevant dependencies between clinical and laboratory findings (signs) and diseases. In particular, we include disease-disease and sign–sign interactions and study how one can infer the probability of a disease in a patient with given signs. We perform comparative analysis with simple benchmark models to check the performances of our models. We find that including interactions can significantly change the statistical importance of the signs and diseases. This first principles approach, as we show, facilitates the early diagnosis of disease by taking interactions into accounts, and enables the construction of consensus diagnostic flow charts. Additionally, we envision that our approach will find applications in systems biology, and in particular, in characterizing the phenome via the metabolome, the proteome, the transcriptome, and the genome.} }